Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract
Zunhao Zhang,1,* Bo Tian,1,* Hui Xu,1 He Huang,1 Xianwei Liang,1 Changwen Bo,1 Yunfei Bian,1 Ming Wei,2 Zhitao Zhao3 1Department of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China; 2Department of General Surgery, Hebei Key La...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-08-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/investigating-the-efficacy-and-safety-of-the-cyberknife-system-for-tre-peer-reviewed-fulltext-article-CMAR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849239175507738624 |
|---|---|
| author | Zhang Z Tian B Xu H Huang H Liang X Bo C Bian Y Wei M Zhao Z |
| author_facet | Zhang Z Tian B Xu H Huang H Liang X Bo C Bian Y Wei M Zhao Z |
| author_sort | Zhang Z |
| collection | DOAJ |
| description | Zunhao Zhang,1,&ast; Bo Tian,1,&ast; Hui Xu,1 He Huang,1 Xianwei Liang,1 Changwen Bo,1 Yunfei Bian,1 Ming Wei,2 Zhitao Zhao3 1Department of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China; 2Department of General Surgery, Hebei Key Laboratory of Colorectal Cancer Precision Diagnosis and Treatment, The First Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, People’s Republic of China; 3Intensive Care Unit, The First Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Ming Wei, Department of General Surgery, Hebei Key Laboratory of Colorectal Cancer Precision Diagnosis and Treatment, The First Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, People’s Republic of China, Tel +86-18633888663, Email 314926509@qq.com Zhitao Zhao, Intensive Care Unit, The First Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China, Tel +86-18032808723, Email tsld60@163.comObjective: This study aimed to investigate the effectiveness and safety of CyberKnife in the treatment of primary pancreatic cancer with metastases to the gastrointestinal tract (ie, primary pancreatic adenocarcinoma metastasizing to gastrointestinal organs).Methods: A total of 106 patients with primary pancreatic cancer and metastases to the gastrointestinal tract admitted to our hospital received CyberKnife treatment. Recent treatment efficacy (assessed at 3 months post-treatment), median survival period, pain levels, and adverse reactions were analyzed.Results: Among the 106 patients, 17 cases (16.04%) achieved complete response (CR), 61 cases (57.55%) achieved partial response (PR), 20 cases (18.87%) had stable disease (SD), and 8 cases (7.55%) had progressive disease (PD), resulting in an objective response rate (ORR) of 73.59% and an overall disease control rate (DCR) of 92.45% (98 cases). The one-year and two-year overall survival (OS) rates were 74.53% and 55.66%, respectively, while the local control (LC) rates were 92.45% and 87.74%, respectively. The median OS was 8.17 months (range: 1– 25 months). Mean pain scores (Visual Analog Scale) decreased significantly from 5.38± 1.37 at baseline to 2.01± 0.35 post-treatment (p< 0.001). Abdominal and lumbar pain significantly improved after 2 weeks of radiotherapy. Among the 68 patients with baseline pain who experienced relief, analgesic medication was discontinued in 25 (36.8%) patients, reduced by ≥ 50% in 18 patients (26.5%), and by approximately 25% in 5 patients (7.3%). Quality of life improved in 27 patients, remained stable in 52, and declined in 27, yielding an overall improvement or stabilization rate of 74.53% (79 cases).Conclusion: CyberKnife SBRT appears to be a promising treatment modality for managing primary pancreatic cancer with metastases to the gastrointestinal tract, with minimal adverse reactions.Keywords: CyberKnife, pancreatic cancer, gastrointestinal metastases, stereotactic body radiotherapy, survival outcomes |
| format | Article |
| id | doaj-art-8b191673ec3a4347ae900cb962328ec6 |
| institution | Kabale University |
| issn | 1179-1322 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Cancer Management and Research |
| spelling | doaj-art-8b191673ec3a4347ae900cb962328ec62025-08-20T04:01:09ZengDove Medical PressCancer Management and Research1179-13222025-08-01Volume 17Issue 115891598105568Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal TractZhang ZTian BXu HHuang HLiang XBo CBian YWei MZhao ZZunhao Zhang,1,&ast; Bo Tian,1,&ast; Hui Xu,1 He Huang,1 Xianwei Liang,1 Changwen Bo,1 Yunfei Bian,1 Ming Wei,2 Zhitao Zhao3 1Department of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China; 2Department of General Surgery, Hebei Key Laboratory of Colorectal Cancer Precision Diagnosis and Treatment, The First Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, People’s Republic of China; 3Intensive Care Unit, The First Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Ming Wei, Department of General Surgery, Hebei Key Laboratory of Colorectal Cancer Precision Diagnosis and Treatment, The First Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, People’s Republic of China, Tel +86-18633888663, Email 314926509@qq.com Zhitao Zhao, Intensive Care Unit, The First Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China, Tel +86-18032808723, Email tsld60@163.comObjective: This study aimed to investigate the effectiveness and safety of CyberKnife in the treatment of primary pancreatic cancer with metastases to the gastrointestinal tract (ie, primary pancreatic adenocarcinoma metastasizing to gastrointestinal organs).Methods: A total of 106 patients with primary pancreatic cancer and metastases to the gastrointestinal tract admitted to our hospital received CyberKnife treatment. Recent treatment efficacy (assessed at 3 months post-treatment), median survival period, pain levels, and adverse reactions were analyzed.Results: Among the 106 patients, 17 cases (16.04%) achieved complete response (CR), 61 cases (57.55%) achieved partial response (PR), 20 cases (18.87%) had stable disease (SD), and 8 cases (7.55%) had progressive disease (PD), resulting in an objective response rate (ORR) of 73.59% and an overall disease control rate (DCR) of 92.45% (98 cases). The one-year and two-year overall survival (OS) rates were 74.53% and 55.66%, respectively, while the local control (LC) rates were 92.45% and 87.74%, respectively. The median OS was 8.17 months (range: 1– 25 months). Mean pain scores (Visual Analog Scale) decreased significantly from 5.38± 1.37 at baseline to 2.01± 0.35 post-treatment (p< 0.001). Abdominal and lumbar pain significantly improved after 2 weeks of radiotherapy. Among the 68 patients with baseline pain who experienced relief, analgesic medication was discontinued in 25 (36.8%) patients, reduced by ≥ 50% in 18 patients (26.5%), and by approximately 25% in 5 patients (7.3%). Quality of life improved in 27 patients, remained stable in 52, and declined in 27, yielding an overall improvement or stabilization rate of 74.53% (79 cases).Conclusion: CyberKnife SBRT appears to be a promising treatment modality for managing primary pancreatic cancer with metastases to the gastrointestinal tract, with minimal adverse reactions.Keywords: CyberKnife, pancreatic cancer, gastrointestinal metastases, stereotactic body radiotherapy, survival outcomeshttps://www.dovepress.com/investigating-the-efficacy-and-safety-of-the-cyberknife-system-for-tre-peer-reviewed-fulltext-article-CMARCyberKnifePancreatic cancerGastrointestinal metastasesStereotactic body radiotherapySurvival outcomes |
| spellingShingle | Zhang Z Tian B Xu H Huang H Liang X Bo C Bian Y Wei M Zhao Z Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract Cancer Management and Research CyberKnife Pancreatic cancer Gastrointestinal metastases Stereotactic body radiotherapy Survival outcomes |
| title | Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract |
| title_full | Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract |
| title_fullStr | Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract |
| title_full_unstemmed | Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract |
| title_short | Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract |
| title_sort | investigating the efficacy and safety of the cyberknife system for treating primary pancreatic cancer with metastases to the gastrointestinal tract |
| topic | CyberKnife Pancreatic cancer Gastrointestinal metastases Stereotactic body radiotherapy Survival outcomes |
| url | https://www.dovepress.com/investigating-the-efficacy-and-safety-of-the-cyberknife-system-for-tre-peer-reviewed-fulltext-article-CMAR |
| work_keys_str_mv | AT zhangz investigatingtheefficacyandsafetyofthecyberknifesystemfortreatingprimarypancreaticcancerwithmetastasestothegastrointestinaltract AT tianb investigatingtheefficacyandsafetyofthecyberknifesystemfortreatingprimarypancreaticcancerwithmetastasestothegastrointestinaltract AT xuh investigatingtheefficacyandsafetyofthecyberknifesystemfortreatingprimarypancreaticcancerwithmetastasestothegastrointestinaltract AT huangh investigatingtheefficacyandsafetyofthecyberknifesystemfortreatingprimarypancreaticcancerwithmetastasestothegastrointestinaltract AT liangx investigatingtheefficacyandsafetyofthecyberknifesystemfortreatingprimarypancreaticcancerwithmetastasestothegastrointestinaltract AT boc investigatingtheefficacyandsafetyofthecyberknifesystemfortreatingprimarypancreaticcancerwithmetastasestothegastrointestinaltract AT biany investigatingtheefficacyandsafetyofthecyberknifesystemfortreatingprimarypancreaticcancerwithmetastasestothegastrointestinaltract AT weim investigatingtheefficacyandsafetyofthecyberknifesystemfortreatingprimarypancreaticcancerwithmetastasestothegastrointestinaltract AT zhaoz investigatingtheefficacyandsafetyofthecyberknifesystemfortreatingprimarypancreaticcancerwithmetastasestothegastrointestinaltract |